FDA proposes new lead limits for baby food to reduce potential risks to children’s health

FDA proposes new lead limits for baby food to reduce potential risks to children’s health


Jgi/jamie Grill | Tetra Images | Getty Images

The Food and Drug Administration proposed new limits Tuesday on lead in baby food, in an effort to reduce exposure to a toxin that can impair childhood development.

The lead limits apply to processed food consumed by children younger than two years old. In a statement, FDA Commissioner Dr. Robert Califf said the limits would reduce lead exposure from these foods by as much as 27%.

related investing news

Cowen says buy Regeneron, success of drugs could help pharmaceutical stock

CNBC Pro

The proposed lead limits are not legally binding on the industry, but the FDA said it would use them as a factor in deciding whether to take enforcement action against a company for selling contaminated food.

The agency proposed the following lead concentration limits for baby food:

  • 10 parts per billion for fruits, vegetables, yoghurts, custards and puddings, mixtures, and single ingredient meats. This would reduce exposure by 26%.
  • 20 parts per billion for root vegetables. This would reduce exposure by 27%.
  • 20 parts per billion for dry cereals. This would reduce exposure by 24%.

Lead is toxic and particularly dangerous for young children. It can impair brain development and the nervous system, resulting in learning disabilities and behavioral difficulties.

Lead exposure through food among children ages 1 to 3 has declined 97% since the 1980s, according to the FDA. Though progress has been made over the years, the agency launched an effort in 2021 to reduce the levels of lead, arsenic, cadmium and mercury in children’s food to the greatest extent possible.

Food consumed by children can contain lead due to contaminated water or soil, industrial activity and old lead-containing equipment used to make food, according to the FDA. The agency said it’s not possible to completely remove lead from the food supply, but the limits should push industry to take measures to reduce its presence as much as possible.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Sarepta shares plunge 40% as future of its gene therapy appears at risk
Health

Sarepta shares plunge 40% as future of its gene therapy appears at risk

Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk. The […]

Read More
Trump diagnosed with common vein condition after ankle swelling raises concerns
Health

Trump diagnosed with common vein condition after ankle swelling raises concerns

First Lady Melania Trump, President Donald Trump, FIFA President Gianni Infantino and his wife, Leena Al Ashqar, attend the FIFA Club World Cup 2025 final football match between England’s Chelsea and France’s Paris Saint-Germain at MetLife Stadium in East Rutherford, New Jersey, July 13, 2025. Charly Triballeau | AFP | Getty Images President Donald Trump […]

Read More
Abbott stock fell victim to an old earnings season truth: It’s all about the guidance
Health

Abbott stock fell victim to an old earnings season truth: It’s all about the guidance

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus estimate, according to estimates compiled by LSEG. Organic sales , excluding Covid testing results, […]

Read More